Research Topics
Species | R RubioSummaryAffiliation: Hospital Universitario Country: Spain Publications
| Collaborators
|
Detail Information
Publications
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903Juan Berenguer
Hospital Gregorio Maranon, Madrid, Spain
Clin Infect Dis 47:1083-92. 2008..The combination of didanosine, lamivudine, and efavirenz (ddI/3TC/EFV) for the initial treatment of human immunodeficiency virus type 1 (HIV-1) infection has been insufficiently analyzed in clinical trials...
Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction]Juan Berenguer
Unidad de Enfermedades Infecciosas, Hospital General Gregorio Maranon, Madrid, Spain
Enferm Infecc Microbiol Clin 22:160-76. 2004..To provide an update of guidelines from the Spanish AIDS Study Group (GESIDA) and the National AIDS Plan (PNS) committee on the prevention of opportunistic infections in adult and adolescent HIV-infected patients...
Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapyJuan Berenguer
Hospital Gregorio Maranon, Madrid, Spain
J Acquir Immune Defic Syndr 47:422-8. 2008..We analyzed survival, therapeutic response, and prognostic factors in patients with HIV-related Hodgkin lymphoma (HL) treated or not with highly active antiretroviral therapy (HAART)...
Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapyJuan Berenguer
Infectious Diseases Service of Hospital Gregorio Marañón, 28007, Madrid, Spain
Clin Infect Dis 36:1047-52. 2003..One-third of patients with PML died despite receipt of HAART; neurologic function improved in approximately one-half of the survivors. A CD4+ cell count of <100 cells/microL was associated with higher mortality...
Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patientsJ Berenguer
Hospital Gregorio Maranon, Madrid, Spain
J Antimicrob Chemother 63:1256-63. 2009..We compared the effectiveness and safety of peg-IFN-alpha2a and peg-IFN-alpha2b, both with ribavirin, against chronic hepatitis C virus (HCV) infection in HIV-infected patients...
Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfectionJuan Berenguer
HIV Infectious Diseases Unit, Hospital General Universitario Gregorio Maranon, Madrid, Spain
Clin Infect Dis 46:137-43. 2008....
Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virusJuan Berenguer
Hospital Gregorio Maranon, Madrid, Spain
Hepatology 50:407-13. 2009..CONCLUSION: Our results suggest that the achievement of an SVR after interferon-ribavirin therapy in patients coinfected with HIV/HCV reduces liver-related complications and mortality...
Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohortJuan Berenguer
Infectious Diseases and HIV Unit, Hospital Gregorio Maranon, Madrid, Spain
J Acquir Immune Defic Syndr 41:154-9. 2006..To analyze the safety and effectiveness of abacavir, lamivudine, and zidovudine (ABC/3TC/ZDV) in antiretroviral therapy (ART)-naive HIV-infected patients...
Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory dataJ Berenguer
Infectious Diseases Unit, Hospital General Universitario Gregorio Maranon, Madrid, Spain
J Viral Hepat 14:859-69. 2007..3, and the PPV to confirm F > or = 3 was 64.3%. Thus, HGM-2 accurately predicted F > or = 3 among HIV/HCV-coinfected patients. HGM-1 was less accurate at predicting F > or = 2...
Food sources of nutrients in the diet of Spanish children: the Four Provinces StudyM A Royo-Bordonada
Institute of Health Carlos III, Ministry of Health and Consumer Affairs, Madrid, Spain
Br J Nutr 89:105-14. 2003....
Prevalence of HLA-B*5701 in HIV-infected patients in Spain (results of the EPI Study)J Arrizabalaga
Infectious Diseases Unit, H Donostia, San Sebastian, Spain
HIV Clin Trials 10:48-51. 2009..6% in HIV-infected population. However the prevalence of this allele in HIV-infected patients in Spain has not been established yet...
Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access ProgramM Jesús Pérez-Elías
Hospital Ramon y Cajal, Madrid, Spain
Enferm Infecc Microbiol Clin 27:28-32. 2009..The objective of this study was to collect safety data on treatment with fosamprenavir/ritonavir (FPV/r) 700/100mg BID in HIV-infected patients through an expanded access program...
Hepatitis C in HIV-infected patients--therapeutic approachI Fernandez
Department of Gastroenterology and Hepatology, HIV Unit, Department of Internal Medicine, and Unit of Infectious Diseases, Hospital 12 de Octubre, Madrid, Spain
Clin Microbiol Infect 8:80-4. 2002..However, the limited amount of available information and the complexities of drug interactions between HAART therapy and immunosuppressive drugs oblige us to be prudent within considering such a procedure...
Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapyL Valor
Division of Immunology, University General Hospital Gregorio Marañon, Madrid, Spain
Vaccine 26:2738-45. 2008..Long-term immunization in patients receiving ART helps to develop HIV-1-specific polyfunctional T cell responses...
Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte countE Manas
Departamento de neumologia, Hospital Ramon y Cajal, Madrid, Spain
Int J Tuberc Lung Dis 8:451-7. 2004..To assess the influence of tuberculosis (TB) on the progression of human immunodeficiency virus (HIV) infection in patients without immunological impairment...
Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditionsR Rubio
Internal Medicine Department, HIV Unit, Hospital Universitario 12 de Octubre, Madrid, Spain
HIV Med 11:545-53. 2010..Atazanavir (ATV) boosted with ritonavir (ATV/r) is a potent, well-tolerated, once-daily protease inhibitor (PI). Few data are available on this agent as a treatment simplification option for patients taking other PIs...
Gestational diabetes mellitus in a cohort of HIV-1 infected womenM I González-Tomé
Department of Immunodeficiencies, Hospital 12 de Octubre, Madrid, Spain
HIV Med 9:868-74. 2008..We undertook a prospective study to estimate the prevalence of gestational diabetes mellitus (GDM) and associated risk factors in a cohort of 669 HIV-1 infected women...
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendationsV Soriano
Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain
J Viral Hepat 11:2-17. 2004..These guidelines represent a comprehensive and updated overview on the management of hepatitis B and C in HIV-infected patients...
Study of the validity of a questionnaire to assess the adherence to therapy in patients infected by HIVJ Martin
Research Unit, 11th Health Area, Madrid, Spain
HIV Clin Trials 2:31-7. 2001..The purpose of our study was to examine the validity of a questionnaire to detect nonadherence in HIV-infected patients under antiretroviral treatment...
Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjectsE Fernandez-Cruz
Division of Immunology, Hospital General Universitario Gregorio Maranon, Dr Esquerdo 46, 28007 Madrid, Spain
Vaccine 22:2966-73. 2004..034). The data suggest that therapeutic immunization plus ARTs could influence virologic control...
Outcomes of a health education intervention in a sample of patients infected by HIV, most of them injection drug users: possibilities and limitationsJ Martin
11th Primary Care Area, INSALUD, Madrid, Spain
AIDS Care 13:467-73. 2001..01) and non-adherent women (p = 0.05). We concluded that HIV-infected patients, mainly IDUs, are not receptive to group educational programmes. The design of future interventions must take into account the patients' characteristics...
Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial diseaseJ Olalla
Unidad de Infección VIH, Servicio de Medicina Interna, Hospital Universitario Doce de Octubre, Madrid, Spain
Int J Tuberc Lung Dis 6:71-5. 2002..Paradoxical worsening or relapse of opportunistic infections has been described after initiation of highly active anti-retroviral therapy (HAART) in human immunodeficiency virus (HIV) infected patients...
Chagas disease screening among HIV-positive Latin American immigrants: an emerging problemJ Llenas-García
HIV Unit, Instituto de Investigación Hospital 12 de Octubre I 12, Universidad Complutense de Madrid, Madrid, Spain
Eur J Clin Microbiol Infect Dis 31:1991-7. 2012..012). Units dealing with HIV patients from endemic areas of American trypanosomiasis should implement CD screening protocols. Interviews of patients coming from endemic areas should include CD epidemiological questions...
[Avascular necrosis of the bone in patients with HIV infection: an emergent problem]V J Moreno-Cuerda
Unidad VIH, Hospital Universitario Doce de Octubre, Madrid, Spain
Rev Clin Esp 206:392-6. 2006..We cannot rule out antiretroviral treatment as a risk factor for avascular necrosis of the bone. Case-control studies published have not identified antiretroviral treatment as a risk factor probably due to small size of the samples...
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infectionEsteban Martinez
Infectious Diseases Unit, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
N Engl J Med 349:1036-46. 2003..We assessed the strategy of substituting nevirapine, efavirenz, or abacavir for a protease inhibitor in patients infected with human immunodeficiency virus type 1 (HIV-1) in whom virologic suppression had been achieved...
Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconvertersCarmen de Mendoza
Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain
J Acquir Immune Defic Syndr 48:241-4. 2008..Pure X4 and X4R5 dual-tropic viruses may be recognized in approximately 15% of drug-naive HIV-1-positive patients. CCR5 antagonists are active against R5 viruses; therefore, HIV tropism should be known before their prescription...
Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in SpainS Monge
AIDS Research Network, National Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain
HIV Med 14:273-83. 2013..The objective of the study was to analyse key HIV-related outcomes in migrants originating from Latin America and the Spanish-speaking Caribbean (LAC) or sub-Saharan Africa (SSA) living in Spain compared with native Spaniards (NSP)...
Dietary patterns among children aged 6-7 y in four Spanish cities with widely differing cardiovascular mortalityF Rodriguez-Artalejo
Department of Preventive Medicine and Public Health, Universidad Autonoma de Madrid, Madrid, Spain
Eur J Clin Nutr 56:141-8. 2002..Therefore, this work examines certain anthropometric variables and diet among children aged 6-7 y, living in four Spanish cities with widely differing ischaemic heart disease (IHD) mortality...
Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patientsEsteban Ribera
Infectious Diseases Service, Hospital Universitari Vall d Hebron, Barcelona, Spain
Antivir Ther 10:605-14. 2005..The purpose of this study was to evaluate the efficacy and safety of a once-daily regimen consisting of didanosine (ddI), lamivudine (3TC) and nevirapine (NVP) for adult antiretroviral-naive patients with HIV-1 infection...
[Changing trends in HIV epidemics: recent diagnoses in the Spanish VACH cohort (2000-2002)]Ramon Teira
Servicio de Enfermedades Infecciosas, Hospital de Basurto, Bilbao, Spain
Enferm Infecc Microbiol Clin 23:213-7. 2005..Studying the changing trends of HIV epidemics is a useful means of evaluating the results of current preventive plans as well as of defining future needs and objectives...
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 StudyHernando Knobel
Department of Internal Medicine, Infectious Diseases, Hospital del Mar, Barcelona, Spain
J Acquir Immune Defic Syndr 37:1276-81. 2004..The use of antihistamines remains unclear in this setting. A double-blind placebo-controlled study was performed to evaluate the efficacy of cetirizine in the prevention of nevirapine rash...
Efficacy of recombinant interleukin-2 (rIL-2) in patients with advanced HIV-1 infection and blunted immune response to HAARTManuel Crespo
Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Spain
Enferm Infecc Microbiol Clin 26:27-31. 2008..The primary endpoint was median change in CD4+ T-cell counts at the end of treatment as compared to baseline. Secondary endpoints were safety and changes in the various T-cell subpopulations...
Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/microl or lessElena Ferrer
Infectious Disease Services, Universitari de Bellvitge Hospital, Barcelona, Spain
AIDS 18:1727-9. 2004..More than 80% of patients who continued with nevirapine had viral loads < 50 copies/ml and CD4 cell counts > 200 cells/pl...
First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohortPere Domingo
Hospital de la Santa Creu i Sant Pau, Mas Casanovas 90, 08025 Barcelona, Spain
J Antimicrob Chemother 61:1348-58. 2008..A retrospective longitudinal study from the VACH cohort comparing both regimens was performed...
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene StudyLidia Ruiz
Retrovirology Laboratory, IrsiCaixa Foundation and Lluita contra la SIDA Foundation, Hospital Germans Trias i Pujol, Universitat Autonoma de Barcelona, Barcelona, Spain
J Infect Dis 188:977-85. 2003..66; 95% confidence interval, 0.47-0.93; P=.021). A prior STI seems to confer no additional benefit to subsequent virological or immunological outcomes of a salvage regimen...
Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort)Ignacio Suarez-Lozano
Hospital Infanta Elena, Huelva, Spain
AIDS 16:2496-9. 2002
Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortalityMiriam J Alvarez-Martinez
Hospital Clinic IDIBAPS, Universitat de Barcelona, Barcelona, Spain
Diagn Microbiol Infect Dis 62:34-43. 2008..03 and P < 0.001, respectively). The prevalence of DHPS mutants in Spain is low and is not associated with a worse outcome. Severe respiratory failure at admission is the strongest predictor of PCP outcome...
Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adultsEsteban Ribera
Servicio de Enfermedades Infecciosas, Hospital Universitari Vall d Hebron, Paseo Vall Hebron 119 129, 08035 Barcelona, Spain
Antimicrob Agents Chemother 48:4256-62. 2004....
Hepatitis C virus and human immunodeficiency virus coinfection in SpainBernardino Roca
Hospital General, Castellon, Spain
J Infect 47:117-24. 2003....
Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosisJesus Oliva
AIDS 17:637-8. 2003
Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatmentAndrew Hill
Liverpool University, Liverpool, UK
Expert Opin Pharmacother 8:679-88. 2007....
Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosisEsteban Ribera
Infectious Diseases Department, Hospital Universitari Vall d Hebron, Barcelona, Spain
J Antimicrob Chemother 59:690-7. 2007..To assess plasma steady-state pharmacokinetics (PK) of rifampicin, isoniazid, saquinavir and ritonavir in HIV and tuberculosis (TB) co-infected patients, and investigate potential interactions between TB drugs and protease inhibitors (PIs)...
Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patientsLluis Castells
Liver Unit, Department of Medicine, Hospital Universitari Vail d Hebron, Barcelona, Spain
Antivir Ther 11:1061-70. 2006..To investigate the efficacy of early antiviral treatment for hepatitis C virus (HCV) recurrence in HIV/HCV-coinfected patients undergoing liver transplantation for end-stage liver disease...
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study)Esteban Ribera
Infectious Diseases Service, Hospital Universitari Vall d Hebron, Barcelona, Spain
J Acquir Immune Defic Syndr 40:317-23. 2005....
Value of culture and nested polymerase chain reaction of blood in the prediction of relapses in patients co-infected with leishmania and human immunodeficiency virusCristina Riera
Laboratori de Parasitologia, Facultat de Farmacia, Universitat de Barcelona, Barcelona, Spain
Am J Trop Med Hyg 73:1012-5. 2005..However, the presence of viable parasites during post-treatment follow-up increased the probability of relapse and showed that culture positivity could be a good relapse marker...
[Efavirenz and nevirapine plasma levels in HIV-infected patients with hemophilia]Marta Martorell
Unidad de Hemofilia, Servicio de Farmacia, Hospital Universitario Vall d Hebron, Barcelona, Spain
Enferm Infecc Microbiol Clin 23:349-52. 2005..86 .g/ml (0.82-4.88 .g/ml) in patients with detectable viral load (p = 0.32). Nevirapine plasma concentrations were 4.41 .g/ml (3.50-6.72 .g/ml) and 3.12 .g/ml (2.44-3.80 .g/ml) respectively (p = 0.18)...
Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimenEsteban Ribera
Department of Infectious Diseases, Hospital Universitari Vall d Hebron, Paseo Vall Hebron 119 129, 08035 Barcelona, Spain
AIDS 20:1131-9. 2006..To assess the pharmacokinetics and tolerability of lopinavir (LPV), ritonavir (RTV) and atazanavir (ATV) as a double-boosted protease inhibitor regimen in HIV-infected adults...
Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trialJose M Miro
Institut d Investigacions Biomediques August Pi Sunyer Hospital Clinic, University of Barcelona, Barcelona, Spain
Clin Infect Dis 43:79-89. 2006..To our knowledge, no randomized trials have evaluated whether prophylaxis against toxoplasmic encephalitis can be safely discontinued after the CD4+ T cell count increases in response to highly active antiretroviral therapy...
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapineCesar Fisac
Nutrition Section, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
AIDS 19:917-25. 2005..To evaluate the 24-month metabolic and morphological benefits obtained from replacing the protease inhibitor (PI) in a regimen with nevirapine, efavirenz or abacavir...
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimenCecilia Cabrera
IrsiCaixa Foundation and Lluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
AIDS 20:2075-80. 2006..To analyse the genetic changes in the gp41 protein in HIV-infected patients with detectable plasma viraemia receiving a long-term salvage enfuvirtide regimen...
Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patientsManuel Crespo
Infectious Diseases Department, Hospital Universitari Vail d Hebron, Universitat Autonoma de Barcelona, Spain
Antivir Ther 12:1217-23. 2007..Therefore, it has been suggested that monitoring RBV serum levels could be used to drive dose modification and to optimize management of HCV-infected patients receiving combination treatment...
Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized studyDaniel Podzamczer
Infectious Disease Service, Hospital Universitari de Bellvitge, Barcelona, Spain
J Acquir Immune Defic Syndr 44:139-47. 2007..To assess lipoatrophy, other toxicities, and efficacy associated with abacavir as compared with stavudine in HIV-infected antiretroviral-naive patients...
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patientsEsteban Martinez
Hospital Clinic, Barcelona, Spain
AIDS 21:367-9. 2007..In contrast, abacavir showed a lower incidence of adverse effects leading to drug discontinuation...
Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patientsManuel Crespo
Infectious Diseases Department, Spain
AIDS 21:477-81. 2007..To investigate the utility of a week-4 virological response for sustained response prediction in hepatitis C virus (HCV) genotype 3/HIV-co-infected patients treated with interferon and ribavirin for 24 weeks...
Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literatureVicente Falco
Infectious Diseases Division, Hospital Vall d Hebron, 08035 Barcelona, Spain
Clin Infect Dis 34:838-46. 2002..17; 95% CI, 0.04-0.73). We conclude that specific therapy with cofactors may improve the outcome for patients with this syndrome...
[Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection]Nuria Vallejo Camazón
Servicios de Cardiología, Hospital General Vall d Hebron, Barcelona, Spain
Rev Esp Cardiol 55:878-81. 2002..We report a case of QT prolongation and development of ventricular arrhythmia in one HIV patient that started with intravenous clarithromycin and cotrimoxazole therapy...
Liver transplantation in HIV-HCV coinfected patients: a case-control studyLluis Castells
Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
Transplantation 83:354-8. 2007..1%) of the control group and one patient (20%) of the HIV group presented a sustained virologic response (P=NS). Short- to midterm results of LT in HIV-HCV co-infected patients were excellent and similar to non-HIV patients...
[Spanish recommendations for proper use of enfuvirtide]Esteban Ribera
Hospital Vall d Hebron, Barcelona, Espana
Enferm Infecc Microbiol Clin 25:131-42. 2007....
Lactic acidosis related to nucleoside therapy in HIV-infected patientsVicenc Falco
Infectious Diseases Division, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, P masculine Vall d Hebron 119 129 08035, Barcelona, Spain
Expert Opin Pharmacother 4:1321-9. 2003..Therapy is based on supportive measures and discontinuation of all antiretroviral drugs. Administration of essential vitamin coenzymes, electron acceptors and L-carnitine may be useful in some cases...
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot studyFernando Laguna
Servicio de Enfermedades Infecciosas, Hospital Carlos III, Instituto de Salud Carlos III, C Sinesio Delgado 12, 28029 Madrid, Spain
J Antimicrob Chemother 52:464-8. 2003..0006). The efficacy of ABLC is similar to meglumine antimoniate, but the severity of toxicity in the treatment of HIV-VL is lower with ABLC...
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitorsEsteban Martinez
Hospital Clinic IDIBAPS, Barcelona, Spain
Antivir Ther 8:403-10. 2003..Whether a therapeutic approach addressed to those metabolic abnormalities may have any impact on body fat is not clear...
